Zobrazeno 1 - 10
of 99
pro vyhledávání: '"Yoshitaka ARASE"'
Autor:
Jin Imai, Shinji Takashimizu, Nana Suzuki, Kana Ohshinden, Kana Sawamoto, Yusuke Mishima, Kota Tsuruya, Yoshitaka Arase, Mitsuhiko Yamano, Noriaki Kishimoto, Chizumi Yamada, Nagamu Inoue, Kengo Moriyama, Akiyasu Baba, Hidekazu Suzuki, Tatehiro Kagawa, Yasuhiro Nishizaki
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-7 (2024)
Abstract A novel concept of Metabolic Associated Fatty Liver Disease (MAFLD) was proposed, incorporating metabolic abnormalities such as obesity and diabetes, which are risk factors that affect the prognosis. Non-Alcoholic Fatty Liver Disease (NAFLD)
Externí odkaz:
https://doaj.org/article/754dd757f5864b4b8113368be53e7250
Autor:
Mia FUJISAWA, Ryuzo DEGUCHI, Takashi UEDA, Erika TERAMURA, Masaya SANO, Hirohiko SATO, Yoshitaka ARASE, Hidekazu SUZUKI, Masashi MATSUSHIMA, Tatehiro KAGAWA
Publikováno v:
Tokai Journal of Experimental & Clinical Medicine; Dec2024, Vol. 49 Issue 4, p140-143, 4p
Autor:
Tatehiro Kagawa, Kota Tsuruya, Jun Koizumi, Yuka Sekiguchi, Shun Ono, Tatsuya Sekiguchi, Takuya Hara, Yusuke Mishima, Yoshitaka Arase, Shunji Hirose, Koichi Shiraishi
Publikováno v:
BMJ Open Gastroenterology, Vol 10, Iss 1 (2023)
Objective Ascites in patients with decompensated cirrhosis can lead to abdominal distention and decrease quality of life. Tolvaptan, a vasopressin V2 receptor antagonist, is an effective agent in the treatment of ascites, whereas some patients are re
Externí odkaz:
https://doaj.org/article/371689667e7248c8b3298005988c34ef
Autor:
Kota Tsuruya, Yasuhiro Nishizaki, Masayuki Tatemichi, Yusuke Mishima, Yoshimasa Shimma, Yoshitaka Arase, Shunji Hirose, Koichi Shiraishi, Tatehiro Kagawa
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-8 (2022)
Abstract The prevalence of hepatic cysts in the general population and their natural history are largely unknown. This study aimed to assess the prevalence and natural history of hepatic cysts by investigating health checkup participants. Ultrasonogr
Externí odkaz:
https://doaj.org/article/0ac3e45c0af84805a02f89ac354f97c9
Autor:
Ryuzo Deguchi, Takashi Ueda, Motoki Kaneko, Yoshitaka Arase, Kota Tsuruya, Aya Kawanishi, Toshiki Kodama, Masashi Morimachi, Takashi Ogimi, Tatehiro Kagawa
Publikováno v:
Internal Medicine; 2024, Vol. 63 Issue 18, p2519-2523, 5p
Autor:
Yusuke MISHIMA, Kota TSURUYA, Yosuke TAZAWA, Yoshitaka ARASE, Shunji HIROSE, Koichi SHIRAISHI, Masayuki TANAKA, Sanae ISAKI, Tsuneo KITAMURA, Tatehiro KAGAWA
Publikováno v:
Tokai Journal of Experimental & Clinical Medicine; Sep2024, Vol. 49 Issue 3, p133-136, 4p
Autor:
Erika TERAMURA, Ryuzo DEGUCHI, Takashi UEDA, Masashi MORIMACHI, Masaya SANO, Hirohiko SATO, Mia FUJISAWA, Kota TSURUYA, Yoshitaka ARASE, Tatehiro KAGAWA
Publikováno v:
Tokai Journal of Experimental & Clinical Medicine; Sep2024, Vol. 49 Issue 3, p122-127, 6p
Autor:
Jin Imai, Toru Hanamura, Aya Kawanishi, Takashi Ueda, Yusuke Mishima, Ayano Ito, Yoshihiro Shirataki, Masashi Morimachi, Toshio Kodama, Hirohiko Sato, Motoki Kaneko, Masaya Sano, Erika Teramura, Makiko Monma, Shingo Tsuda, Kota Tsuruya, Hajime Mizukami, Yoshitaka Arase, Mia Fujisawa, Saya Miyahara, Naoya Nakamura, Takayoshi Suzuki, Masashi Matsushima, Hidekazu Suzuki, Shinji Takashimizu, Tatehiro Kagawa, Yasuhiro Nishizaki
Publikováno v:
DEN Open, Vol 3, Iss 1, Pp n/a-n/a (2023)
Abstract Breast cancer is one of the most common malignancies in women worldwide. Although most breast cancers are curable, in cases of metastasis, many are often found in the lungs, bones, liver, and central nervous system; however, metastasis to th
Externí odkaz:
https://doaj.org/article/be815ce77edd44318c924ef21e712301
Autor:
Shunji Hirose, Koshi Matsumoto, Masayuki Tatemichi, Kota Tsuruya, Kazuya Anzai, Yoshitaka Arase, Koichi Shiraishi, Michiko Suzuki, Satsuki Ieda, Tatehiro Kagawa
Publikováno v:
PLoS ONE, Vol 15, Iss 11, p e0241770 (2020)
BackgroundMany studies have investigated the prognosis of nonalcoholic fatty liver disease (NAFLD); however, most studies had a relatively short follow-up. To elucidate the long-term outcome of NAFLD, we conducted a retrospective cohort study of pati
Externí odkaz:
https://doaj.org/article/e34c745c53d14f83954e4ebe961ab249
Autor:
Tatsunori Hanai, Hideto Kawaratani, Junji Nagano, Hirokazu Suii, Akira Sakamaki, Yoshitaka Arase, Hiroyuki Nakanishi, Tomomi Kogiso, Tomomi Okubo, Takao Miwa, Shogo Shimizu, Shuhei Hige, Masanori Atsukawa, Masahito Shimizu, Masayuki Kurosaki, Shuji Terai, Tatehiro Kagawa, Katsutoshi Tokushige, Hitoshi Yoshiji
Publikováno v:
Hepatology Research. 53:238-246
Cell-free and concentrated ascites reinfusion therapy (CART) and large-volume paracentesis (LVP) with albumin infusion are useful for managing refractory ascites (RA). However, it remains unclear which therapy is more effective in patients with cirrh